Embedded Files
COVID-19 and influenza can cause similar respiratory symptoms, making rapid differentiation between these infections valuable in supporting clinical assessment. The Biopanda COVID-19 and Influenza A+B Ag Combo Rapid Test provides a convenient multiplex solution for the simultaneous detection of SARS-CoV-2 and Influenza A+B antigens from nasal or nasopharyngeal swab samples. Designed for professional use, this COVID-19 and Flu rapid test provides healthcare professionals and clinical laboratories with clear visual results in just 15 minutes, enabling multiple respiratory pathogens to be screened within a single testing procedure.
COVID-19 and Influenza A+B Ag Combo Rapid Test
COVID-19 and Influenza A+B Ag Combo Rapid Test
Catalogue Number: RAPG-RSPV-002
Kit Size: 20 Tests
Assay Time: 15 minutes
Storage: 2-30°C
Specimen: Nasal & Nasopharyngeal Swab
Results: Read visually
Description:
The Biopanda COVID-19 and Influenza A+B Ag Combo rapid test is an immunochromatographic assay for the qualitative detection of SARS-CoV-2 Nucleocapsid protein and Influenza A+B virus antigens present in nasal and nasopharyngeal swab samples.
It is intended for use as a tool to assist in the diagnosis of SARS-CoV-2 and Influenza A+B infections in conjunction with other tests.
This presentation focuses on the importance of combined testing for respiratory infections and how the Biopanda COVID-19 and Influenza A+B Ag Combo Rapid Test can assist with fast and effective diagnosis.
Why Test for COVID-19 and Influenza A+B?
Why Test for COVID-19 and Influenza A+B?
COVID-19 and influenza are respiratory infections that can cause similar symptoms, including fever, cough, fatigue, headache and other respiratory symptoms. Because the clinical presentation of these infections can overlap, testing can help support identification of the potential cause of illness and assist with differential diagnosis.
COVID-19 and Influenza A+B antigen testing provides a convenient method for detecting viral antigens associated with SARS-CoV-2 and influenza infection. Testing for both pathogens simultaneously can be particularly useful when patients present with respiratory symptoms that could be caused by either infection.
A combination respiratory rapid test enables multiple pathogens to be screened from a single patient specimen, providing a more efficient approach than performing separate initial rapid tests for COVID-19 and influenza.
The Biopanda COVID-19 and Influenza A+B Ag Combo Rapid Test qualitatively detects SARS-CoV-2 and Influenza A+B antigens from nasal or nasopharyngeal swab samples, with visually read results in 15 minutes. The test is intended to assist in the diagnosis of SARS-CoV-2 and Influenza A+B infections alongside clinical assessment and other appropriate diagnostic procedures.
How to order:
Via the contact us page, fill in the form with all the necessary details and we will email you back ASAP.
Or, email us directly for general queries (please include the product catalogue number in the subject line, if applicable).
Page updated
Google Sites
Report abuse